Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Cebranopadol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 269,920Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tris Reports Positive Ph3 Alleviate-2 Data For Cebranopadol
    Tris Reports Positive Ph3 Alleviate-2 Data For Cebranopadol

    06 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250306271136/en

    BUSINESSWIRE
    06 Mar 2025
    Share Share
    Tris shows its opioid alternative is less likely to be abused
    Tris shows its opioid alternative is less likely to be abused

    28 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/tris-builds-clinical-case-opioid-alternative-showing-pain-drug-less-likely-be-abused

    FIERCE BIOTECH
    28 Jan 2025
    Share Share
    Tris Pharma's Cebranopadol Shows Prolonged Pain Relief at PAINWeek 2024
    Tris Pharma's Cebranopadol Shows Prolonged Pain Relief at PAINWeek 2024

    03 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240903523518/en

    BUSINESSWIRE
    03 Sep 2024
    Share Share
    Tris Pharma Starts Phase 3 Trials For Novel Pain Treatment Cebranopadol
    Tris Pharma Starts Phase 3 Trials For Novel Pain Treatment Cebranopadol

    22 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240821421996/en

    BUSINESSWIRE
    22 Aug 2024
    Share Share
    Tris Pharma Presents Data On Cebranopadol For Pain Treatment
    Tris Pharma Presents Data On Cebranopadol For Pain Treatment

    06 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240805194778/en

    BUSINESSWIRE
    06 Aug 2024
    Share Share
    Tris Pharma To Present Pain Therapy Data At IASP 2024 Congress
    Tris Pharma To Present Pain Therapy Data At IASP 2024 Congress

    30 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240730108785/en

    BUSINESSWIRE
    30 Jul 2024
    Share Share